×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
RNXT – renovorx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
RNXT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
08:57 am
rnxt
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial [Yahoo! Finance]
Low
Report
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx's Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial [Yahoo! Finance]
11/20
08:45 am
rnxt
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
Medium
Report
Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial
11/14
08:12 am
rnxt
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
Low
Report
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
11/14
08:00 am
rnxt
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights
Low
Report
RenovoRx Reports Third Quarter 2024 Financial Results and Operational Highlights
9/26
07:46 am
rnxt
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Medium
Report
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully [Yahoo! Finance]
9/25
08:30 am
rnxt
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
Low
Report
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians
9/19
08:30 am
rnxt
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
Medium
Report
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer
9/12
08:11 am
rnxt
RenovoRx, Inc. (NASDAQ: RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $8.00 to $8.25. They now have a "buy" rating on the stock.
Medium
Report
RenovoRx, Inc. (NASDAQ: RNXT) had its price target raised by analysts at Ascendiant Capital Markets from $8.00 to $8.25. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
08:31 am
rnxt
Form 8-K RenovoRx, Inc. For: Nov 14
Low
Report
Form 8-K RenovoRx, Inc. For: Nov 14
11/13
04:16 pm
rnxt
Form 10-Q RenovoRx, Inc. For: Sep 30
Medium
Report
Form 10-Q RenovoRx, Inc. For: Sep 30
10/2
04:30 pm
rnxt
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Spiegel Robert J.
Low
Report
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Spiegel Robert J.
10/2
04:30 pm
rnxt
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Macfarlane K. Angela
Low
Report
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Macfarlane K. Angela
10/2
04:30 pm
rnxt
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Marton Laurence
Low
Report
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: Marton Laurence
10/2
04:30 pm
rnxt
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: RYAN UNA S
Low
Report
Form 4 RenovoRx, Inc. For: Oct 01 Filed by: RYAN UNA S
9/25
04:10 pm
rnxt
Form 8-K RenovoRx, Inc. For: Sep 25
Low
Report
Form 8-K RenovoRx, Inc. For: Sep 25
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: